ArticleEpigenomics2025
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines.
Maryam Latarani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleEpigenomics2025
Maryam Latarani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.